Takeda Pharmaceutical Company Limited has disclosed favorable top-line outcomes from a Phase 2, randomized, double-blind, placebo-controlled trial, assessing the safety, tolerability, and efficacy of mezagitamab (TAK-079) in individuals with persistent or chronic primary immune thrombocytopenia (ITP). The study, known as TAK-079-1004 (NCT04278924), explored the impact of three different doses of subcutaneous mezagitamab versus placebo, administered […]
Arthritis, characterized by joint inflammation, can cause immense pain and restrict physical movements, leading to frustration for those affected. However, there are several home remedies that can help manage arthritis and alleviate its symptoms. In this article, we will explore some effective natural remedies for arthritis. Managing your mind as the primary treatment of arthritis […]
New Delhi, Mar 05 (ANI): A study led by researchers at Washington University School of Medicine in St. Louis, has identified, in mice, a process that may prevent antibody-mediated rejection in lung transplants and lead to the development of therapies to treat this form of rejection. One particularly deadly form of rejection — called antibody-mediated […]